New York, NY -- (ReleaseWire) -- 02/25/2013 --Medical Marijuana, Inc. (OTC Pink: MJNA) announced that its Dixie Brand was in the news again. This time, the folks from WCVB Channel 5 Boston brought their cameras out and went inside Dixie Elixirs facility in Denver to see what the future of medical cannabis is like. Massachusetts recently made medical cannabis legal and MJNA is looking forward to serving patients there soon.
Medical Marijuana Inc. operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products, to whole plant or isolated high value extracts specifically manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. Medical Marijuana, Inc. was founded in 2009 and is based in San Diego, California.
Get the daily trend analysis report on MJNA here:
MediSwipe, Inc. (OTCQB: MWIP) announced that it has received commission based revenues on over $1,000,000 in elective medical consumer financing for the months of January and February 2013.
"This new vertical market has quickly proven to be an important revenue stream for our company as it utilizes our unique and long time banking relationships as we begin to roll out our payment kiosks over the next two quarters. MediSwipe has the opportunity to become the 'LendingTree' for the elective surgery industry as our banking and financing network can for the most part get anyone approved for plastic surgery, dental work, Lasik, and numerous other procedures with less than perfect credit. “stated B. Michael Friedman, CEO of MediSwipe Inc.
MediSwipe Inc. provides innovative patient solutions for electronically processing transactions within the healthcare industry.
Find out if this is the right moment for investors to trade MWIP here: http://www.wallstreetreport.net/market-scan/?symbol=MWIP
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit: http://www.wallstreetreport.net/disclaimer-2/
WALL STREET REPORT